Talk:Jeffrey Leiden: Difference between revisions
Re |
→Edit request to update the Vertex section: Marking as answered |
||
Line 3: | Line 3: | ||
== Edit request to update the Vertex section == |
== Edit request to update the Vertex section == |
||
{{request edit}} |
{{request edit|A}} |
||
Hi. I am John and I would like to request some updates to Jeffrey Leiden's article. |
Hi. I am John and I would like to request some updates to Jeffrey Leiden's article. |
||
Line 18: | Line 18: | ||
Thank you for your help, [[User:JohnDatVertex|JohnDatVertex]] ([[User talk:JohnDatVertex|talk]]) 17:43, 1 April 2022 (UTC) |
Thank you for your help, [[User:JohnDatVertex|JohnDatVertex]] ([[User talk:JohnDatVertex|talk]]) 17:43, 1 April 2022 (UTC) |
||
:{{tick}} Partially done, as the sources provided for #1 said no such thing, and I'm not sure about the reliability of #2's. [[User:PK650|PK650]] ([[User talk:PK650|talk]]) 07:45, 3 April 2022 (UTC) |
:{{tick}} Partially done, as the sources provided for #1 said no such thing, and I'm not sure about the reliability of #2's. [[User:PK650|PK650]] ([[User talk:PK650|talk]]) 07:45, 3 April 2022 (UTC) |
||
::I am marking this request as answered, per the above. [[User:Z1720|Z1720]] ([[User talk:Z1720|talk]]) 14:36, 5 April 2022 (UTC) |
Revision as of 14:36, 5 April 2022
This article must adhere to the biographies of living persons (BLP) policy, even if it is not a biography, because it contains material about living persons. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libellous. If such material is repeatedly inserted, or if you have other concerns, please report the issue to this noticeboard.If you are a subject of this article, or acting on behalf of one, and you need help, please see this help page. |
Biography Unassessed | |||||||
|
The Wikimedia Foundation's Terms of Use require that editors disclose their "employer, client, and affiliation" with respect to any paid contribution; see WP:PAID. For advice about reviewing paid contributions, see WP:COIRESPONSE.
|
Edit request to update the Vertex section
It is requested that an edit be made to the semi-protected article at A. (edit · history · last · links · protection log)
This template must be followed by a complete and specific description of the request, that is, specify what text should be removed and a verbatim copy of the text that should replace it. "Please change X" is not acceptable and will be rejected; the request must be of the form "please change X to Y".
The edit may be made by any autoconfirmed user. Remember to change the |
Hi. I am John and I would like to request some updates to Jeffrey Leiden's article.
- Please add the following sentence as a new paragraph in the correct chronological order in the Vertex section, after the sentence that begins "In 2015 Vertex shareholders..." "The 2019 acquisition of Semma Therapeutics led to VX-880, the first potentially curative stem cell-based therapy for patients with type 1 diabetes.[1][2]
- At the end of the sentence that begins "On October 24, 2019, Vertex reached..." please remove Scotland and Spain and replace with Ireland[3] and [[France][4], among others.
- Also in the Vertex section, please add the following as a new paragraph below the sentence that begins "On October 24, 2019, Vertex reached an agreement..." "While Leiden served as chairman, the market capitalization of Vertex Pharmaceuticals increased from $7.74 billion at the beginning of 2012 to $69.97 billion in April 2020.[5][6]
- In the last paragraph of the Vertex section, please change April 2023 to April 2024.[7]
References
- ^ Gelman, Max (29 January 2021). "The diabetes 'cure' Vertex acquired in its 2019 Semma buyout? It's headed to the clinic". Endpoints News.
- ^ Bell, Jacob (10 March 2021). "Vertex begins human testing for diabetes cell therapy". BiopharmaDive.
- ^ "Landmark NHS deal to open up access to life-changing cystic fibrosis drug". EnglandNHS. 21 August 2020.
- ^ Bruce, Francesca (15 July 2021). "Vertex Inks New Cystic Fibrosis Deals In Europe". Pink Sheet.
- ^ "VRTX Market Cap History". Market Cap History. 31 January 2022.
- ^ "Market capitalization of Vertex Pharmaceuticals (VRTX)". Companies Market Cap. 31 March 2022.
- ^ "UNITED STATES SECURITIES AND EXCHANGE COMMISSION Form 10-K". investors.vrtx.com. SEC.
Thank you for your help, JohnDatVertex (talk) 17:43, 1 April 2022 (UTC)
Partially done, as the sources provided for #1 said no such thing, and I'm not sure about the reliability of #2's. PK650 (talk) 07:45, 3 April 2022 (UTC)
- I am marking this request as answered, per the above. Z1720 (talk) 14:36, 5 April 2022 (UTC)